Yichuan Yuan
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 2
-
- Cancer, Hypoxia, and Metabolism 3
-
- Cancer Mechanisms and Therapy 3
-
- Ferroptosis and cancer prognosis 4
- Lung Cancer Treatments and Mutations 3
-
- Liver Disease Diagnosis and Treatment 7
-
- RNA modifications and cancer 5
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yichuan Yuan
18 papers receiving 263 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Hepatology 135
- Cancer Research 70
- Pathology and Forensic Medicine 46
- Oncology 60
- Pulmonary and Respiratory Medicine 62
Countries citing papers authored by Yichuan Yuan
This map shows the geographic impact of Yichuan Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichuan Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichuan Yuan more than expected).
Fields of papers citing papers by Yichuan Yuan
This network shows the impact of papers produced by Yichuan Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichuan Yuan. The network helps show where Yichuan Yuan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yichuan Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 16 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 3 | |
| 9 | TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching studybreakdown → | 2023 | 71 |
| 10 | 2023 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 53 | |
| 15 | A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade. | 2022 | 3 |
| 16 | 2022 | 1 | |
| 17 | 2021 | 28 | |
| 18 | 2021 | 12 | |
| 19 | 2020 | 17 | |
| 20 | 2019 | 27 |
About Yichuan Yuan
Yichuan Yuan is a scholar working on Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 265 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (7 papers), RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Mechanisms and Therapy (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Hepatology (135 citations), Cancer Research (70 citations) and Pathology and Forensic Medicine (46 citations). Yichuan Yuan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Binkui Li, Jiliang Qiu, Yunfei Yuan, Yunxing Shi, Yun Zheng, Wei He, Chenwei Wang, Dinglan Zuo, Minshan Chen and Wan Yee Lau. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.